Literature DB >> 23188490

Validation of the menstrual pictogram in women with leiomyomata associated with heavy menstrual bleeding.

Lois Larsen1, Karin Coyne, Kristof Chwalisz.   

Abstract

OBJECTIVE: The menstrual pictogram (MP), a semiquantitative, easy-to-use tool to assess blood loss, was validated against the reference standard of alkaline hematin (AH) quantitation using data pooled from 3 clinical trials.
METHODS: Premenopausal women aged ≥18 years with heavy menstrual bleeding (HMB) associated with uterine leiomyomata were randomized to asoprisnil (10 or 25 mg) or placebo. Patients completed the MP and collected feminine hygiene products for assessment of blood loss by the AH method. Agreement between the MP and the AH method was calculated.
RESULTS: The positive predictive value of the MP total to distinguish women with HMB against the AH total was 91%. The agreement (κ-statistic) between AH and MP totals for classifying patients with ≥50% or <50% decreases in HMB was 0.88 (95% confidence interval [CI], 0.78-0.98), and the MP was 96% sensitive and 92% specific. The methods showed good association for percentage change in blood (intraclass correlation coefficient [ICC] of 0.86, 95% CI, 0.80-0.91) but not for actual blood loss per cycle (ICC of 0.64, [95% CI, 0.55-0.71]); the greatest underestimation occurred for severely stained napkins.
CONCLUSION: In this study, the MP distinguished women with HMB and adequately assessed improvements with therapy.

Entities:  

Keywords:  alkaline hematin; heavy menstrual bleeding; leiomyomata; menstrual pictogram; validation

Mesh:

Substances:

Year:  2012        PMID: 23188490     DOI: 10.1177/1933719112463252

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  5 in total

1.  A systematic review of methods to measure menstrual blood loss.

Authors:  Julia L Magnay; Shaughn O'Brien; Christoph Gerlinger; Christian Seitz
Journal:  BMC Womens Health       Date:  2018-08-22       Impact factor: 2.809

2.  A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids.

Authors:  M P Diamond; E A Stewart; A R W Williams; B R Carr; E R Myers; R A Feldman; W Elger; C Mattia-Goldberg; B M Schwefel; K Chwalisz
Journal:  Hum Reprod Open       Date:  2019-11-04

3.  Is menstruation a valid reason to postpone cardiac surgery?

Authors:  Devishree Das; Suruchi Hasija; Sandeep Chauhan; Velayoudam Devagourou; Aparna K Sharma; Maroof Ahmad Khan
Journal:  Ann Card Anaesth       Date:  2022 Jul-Sep

4.  Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study.

Authors:  Constantine Scordalakes; Robert delRosario; Andrew Shimer; Russell Stankiewicz
Journal:  Int J Womens Health       Date:  2018-04-18

5.  Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review.

Authors:  Julia L Magnay; Shaughn O'Brien; Christoph Gerlinger; Christian Seitz
Journal:  BMC Womens Health       Date:  2020-02-10       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.